Financial reports
10-Q
2024 Q1
Quarterly report
2 Feb 24
ARS
2023 FY
Annual report to shareholders
5 Jan 24
10-K
2023 FY
Annual report
21 Nov 23
10-Q
2023 Q3
Quarterly report
7 Aug 23
10-Q
2023 Q2
Quarterly report
8 May 23
10-Q
2023 Q1
Quarterly report
7 Feb 23
10-K
2022 FY
Annual report
28 Nov 22
10-Q
2022 Q3
Quarterly report
8 Aug 22
10-Q
2022 Q2
Quarterly report
6 May 22
Current reports
8-K
Submission of Matters to a Vote of Security Holders
7 Feb 24
8-K
Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results
2 Feb 24
8-K
Twist Bioscience Appoints Adam Laponis as Chief Financial Officer
5 Jan 24
8-K
Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2023 Financial Results
17 Nov 23
8-K
Twist Bioscience Reports Fiscal Third Quarter 2023 Financial Results
4 Aug 23
8-K/A
Cost Associated with Exit or Disposal Activities
4 Aug 23
8-K
Twist Bioscience Appoints Robert Werner as Chief Accounting Officer
23 May 23
8-K
Twist Bioscience Reports Fiscal Second Quarter 2023 Financial Results
5 May 23
8-K
Departure of Directors or Certain Officers
28 Mar 23
8-K
Submission of Matters to a Vote of Security Holders
8 Feb 23
Registration and prospectus
S-8
Registration of securities for employees
21 Nov 23
S-8
Registration of securities for employees
24 Aug 23
S-3ASR
Automatic shelf registration
5 Jun 23
S-8
Registration of securities for employees
28 Nov 22
424B5
Prospectus supplement for primary offering
14 Feb 22
424B5
Prospectus supplement for primary offering
9 Feb 22
424B7
Prospectus with selling stockholder info
2 Dec 21
S-8
Registration of securities for employees
9 Aug 21
424B7
Prospectus with selling stockholder info
30 Jun 21
424B5
Prospectus supplement for primary offering
4 Dec 20
Proxies
DEF 14A
Definitive proxy
5 Jan 24
DEF 14A
Definitive proxy
6 Jan 23
DEF 14A
Definitive proxy
4 Jan 22
DEF 14A
Definitive proxy
7 Jan 21
DEF 14A
Definitive proxy
8 Jan 20
DEF 14A
Definitive proxy
14 Jun 19
Other
EFFECT
Notice of effectiveness
16 Dec 19
CORRESP
Correspondence with SEC
12 Dec 19
CORRESP
Correspondence with SEC
20 Nov 19
UPLOAD
Letter from SEC
19 Nov 19
EFFECT
Notice of effectiveness
9 May 19
CORRESP
Correspondence with SEC
6 May 19
CORRESP
Correspondence with SEC
6 May 19
UPLOAD
Letter from SEC
24 Apr 19
CT ORDER
Confidential treatment order
6 Nov 18
EFFECT
Notice of effectiveness
31 Oct 18
Ownership
144
Notice of proposed sale of securities
23 Apr 24
4
Adam Laponis
11 Apr 24
144
Notice of proposed sale of securities
9 Apr 24
4
Patrick John Finn
4 Apr 24
4
William Banyai
4 Apr 24
4
Dennis Cho
4 Apr 24
4
Emily M. Leproust
4 Apr 24
4
Paula Green
4 Apr 24
144/A
Notice of proposed sale of securities (amended)
2 Apr 24
144
Notice of proposed sale of securities
2 Apr 24